Targeting cancer cells with nucleic acid aptamers.
Aptamers are short, structured, single-stranded RNA or DNA ligands that bind with high affinity to their target molecules, which range from small chemicals to large cell-surface and transmembrane proteins. Aptamers are now emerging as promising molecules to target specific cancer epitopes in clinical diagnosis and therapy. Furthermore, because of their high specificity and low toxicity, aptamers might be considered as the compounds-of-choice for in vivo cell recognition. Specific cancer cell recognition could be capitalized upon for delivering therapeutic nanoparticles, small interfering RNA bioconjugates, chemotherapeutic cargos or molecular imaging probes. In this article, we review recent advances in the use of aptamers for in vivo cancer cell recognition, with a particular focus on novel applications of aptamers for targeting the cell surface.
Cerchia
Laura
L
Istituto per l'Endocrinologia e l'Oncologia Sperimentale del CNR "G. Salvatore", Via S. Pansini 5, 80131 Naples, Italy. cerchia@unina.it
de Franciscis
Vittorio
V
D000818:Animals; D052157:Aptamers, Nucleotide / Q000737:chemistry / Q000627:therapeutic use*; D020650:Combinatorial Chemistry Techniques; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
D052157:Aptamers, Nucleotide